收藏切换
Analytical quality by design in biopharmaceutical method development: from current perspectives to practical applications
收藏切换
Xu-hua DUAN, Zhuo-wei SHI, Ming-ren WANG, Shan-shan DONG, Hong SHAO*
Acta Pharmaceutica Sinica | 2025, 60(10) : 2983 - 2994
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(10): 2983-2994
• Reviews •
Analytical quality by design in biopharmaceutical method development: from current perspectives to practical applications
Full
Xu-hua DUAN, Zhuo-wei SHI, Ming-ren WANG, Shan-shan DONG, Hong SHAO*
Affiliations
  • NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai Institute for Food and Drug Control, Shanghai 201203, China
Published: 2025-10-12 doi: 10.16438/j.0513-4870.2025-0266
Outline
收藏切换

Biologics have experienced rapid development on a global scale in recent years. Their analytical techniques, encompassing molecular structural characterization, purity and impurities analyses, function and stability assessment, play a crucial role in ensuring biologics' quality. Quality by design (QbD), as a systematic approach, has been widely adopted in the pharmaceutical industry to optimize manufacturing processes and ensure the reliability of final product quality. Derived from QbD, analytical quality by design (AQbD) ensures the quality of analytical methods by providing confidence and assurance in their development. AQbD begins with defining the analytical target profile (ATP) and employs risk assessment to identify and analyze critical method attributes (CMAs) and critical method parameters (CMPs). By design of experiments (DoE), mathematical models are constructed to explore the relationships between CMPs and CMAs, ultimately establishing the method operable design region (MODR) and an analytical control strategy. Compared to traditional analytical method development, AQbD-based methods offer greater robustness within the MODR, reducing the occurrence of out-of-trend (OOT) or out-of-specification (OOS) results due to method-related factors. This, in turn, enhances regulatory flexibility and reduces analytical costs. This review outlines the AQbD workflow, discusses its current applications in biologics analytical method development, and explores the opportunities and challenges associated with its implementation in this field.

biologics  /  analytical method development  /  analytical quality by design  /  analytical target profile  /  method operable design region  /  analytical control strategy
段徐华, 史卓维, 王鸣人, 董闪闪, 邵泓. 生物药物分析方法开发中的质量设计: 从当前观点到实际应用. 药学学报, 2025 , 60 (10) : 2983 -2994 . DOI: 10.16438/j.0513-4870.2025-0266
Xu-hua DUAN, Zhuo-wei SHI, Ming-ren WANG, Shan-shan DONG, Hong SHAO. Analytical quality by design in biopharmaceutical method development: from current perspectives to practical applications[J]. Acta Pharmaceutica Sinica, 2025 , 60 (10) : 2983 -2994 . DOI: 10.16438/j.0513-4870.2025-0266
Year 2025 volume 60 Issue 10
276
124
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0266
  • Receive Date:2025-03-11
  • Online Date:2026-09-20
  • Published:2025-10-12
Article Data
Affiliations
History
  • Received:2025-03-11
  • Revised:2025-07-12
Affiliations
    NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai Institute for Food and Drug Control, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0266
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT